Experience

We have completed more than 300 studies between Phase I and Phase IV studies.

In data management studies alone, between 50 and 7,000 patients /study have been involved and in IVRS/IWS between 18 and 17.000 patients/study, all spread over 62 countries.

We have gained a preferred supplier status from small biotech to the largest global pharmaceutical companies.

Our preferred provider relationships with several international pharmaceutical and biotechnology companies bear witness to our reputation.